Medicare Enrolled
Dr. Andreas Pavlides, MD
Cardiovascular Disease · Haddon Heights, NJ
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pavlides from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pavlides?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pavlides
Dr. Andreas Pavlides is a cardiovascular disease specialist in Haddon Heights, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pavlides performed 5,324 Medicare services across 3,917 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pavlides received a total of $64,729 from 43 pharmaceutical and/or device companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pavlides is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in NJ
$64,729 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,324
Medicare services
Top 13% in NJ for cardiovascular disease
3,917
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~266 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
770 | $11 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
667 | $99 | $249 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
539 | $7 | $25 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
503 | $157 | $549 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
499 | $66 | $133 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
452 | $41 | $65 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
300 | $110 | $293 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
267 | $52 | $120 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
157 | $41 | $70 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
122 | $16 | $120 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
119 | $31 | $143 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
119 | $12 | $69 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 101 | $640 | $1,067 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
98 | $2,188 | $4,900 |
| Heart muscle strain imaging | 81 | $32 | $85 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
64 | $8 | $25 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
60 | $53 | $279 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $132 | $340 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
56 | $167 | $396 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
54 | $21 | $50 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
54 | $765 | $2,400 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
48 | $8 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $122 | $335 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
21 | $384 | $961 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
21 | $86 | $128 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $142 | $428 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $101 | $203 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
13 | $21 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.4% high complexity
21.6% medium
69.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$64,729
Total received (2018-2024)
Avg $9,247/year across 7 years
Top 4% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
657
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55,960 (86.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,769 (13.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$869
2023
$5,295
2022
$13,363
2021
$4,303
2020
$4,342
2019
$13,429
2018
$23,128
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Impulse Dynamics (USA) Inc.
$253
Novartis Pharmaceuticals Corporation
$185
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$63
CVRx, Inc.
$52
Amgen Inc.
$50
Bayer Healthcare Pharmaceuticals Inc.
$41
Abbott Laboratories
$31
Kiniksa Pharmaceuticals International, plc
$29
Janssen Pharmaceuticals, Inc
$20
Boston Scientific Corporation
$19
Alnylam Pharmaceuticals Inc.
$18
Inspire Medical Systems, Inc.
$17
Azurity Pharmaceuticals, Inc.
$17
PFIZER INC.
$16
Esperion Therapeutics, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Acarix USA Inc.
$13
Top 3 companies account for 57.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$30,592
BOSTON SCIENTIFIC CORPORATION
$24,827
Amgen Inc.
$1,183
Abbott Laboratories
$922
Janssen Pharmaceuticals, Inc
$871
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$763
SANOFI-AVENTIS U.S. LLC
$719
Impulse Dynamics (USA) Inc.
$690
Novartis Pharmaceuticals Corporation
$684
AstraZeneca Pharmaceuticals LP
$486
Esperion Therapeutics, Inc.
$486
E.R. Squibb & Sons, L.L.C.
$266
Amarin Pharma Inc.
$259
PFIZER INC.
$242
BIOTRONIK INC.
$239
Kowa Pharmaceuticals America, Inc.
$239
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
Regeneron Healthcare Solutions, Inc.
$151
Actelion Pharmaceuticals US, Inc.
$122
W. L. Gore & Associates, Inc.
$96
Kiniksa Pharmaceuticals, Ltd.
$90
Novo Nordisk Inc
$54
CVRx, Inc.
$52
Bayer HealthCare Pharmaceuticals Inc.
$50
Merck Sharp & Dohme LLC
$46
Daiichi Sankyo Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$41
AltaThera Pharmaceuticals LLC
$39
ATRICURE, INC.
$34
Otsuka America Pharmaceutical, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$29
Astellas Pharma US Inc
$28
ABIOMED
$23
Edwards Lifesciences Corporation
$22
CARDIVA MEDICAL, INC.
$22
Alnylam Pharmaceuticals Inc.
$18
Inspire Medical Systems, Inc.
$17
Azurity Pharmaceuticals, Inc.
$17
Relypsa, Inc.
$15
Acarix USA Inc.
$13
Lundbeck LLC
$12
Merck Sharp & Dohme Corporation
$12
Gilead Sciences, Inc.
$11
Top 3 companies account for 87.4% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Alere i · Arcalyst · BRILINTA · Barostim Neo System · BioMonitor 2 · CADScor System · CARDIOFORM Septal Occluder · CARDIOMEMS · CHANTIX · Confirm Rx · Corlanor · EDARBI · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FORTIFY ASSURA · Fortify Assura · GENERAL THERAPIES · GORE CARDIOFORM Septal Occluder · HeartMate · INJECTAFER · INSPIRE · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LifeVest · Livalo · MULTAQ · NAVITOR · NEXLETOL · NEXLIZET · NORTHERA · OPTIMIZER · Optimizer · Ozempic · PAXLOVID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · SAMSCA · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Closure Device · Veltassa · VersaCross Large Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in NJ.
Geographic Context
Cardiologists within 10 mi
663
Per 100K population
126.5
County median income
$86,384
Nearest hospital
JEFFERSON STRATFORD HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pavlides is a cardiac imaging specialist, with above-average Medicare volume (top 13% in NJ), with speaking/promotional industry engagement in the top 4% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pavlides experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Pavlides performed 770 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pavlides receive payments from pharmaceutical companies?
Yes. Dr. Pavlides received a total of $64,729 from 43 companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pavlides's costs compare to other cardiologists in Haddon Heights?
Dr. Pavlides's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pavlides) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Haddon Heights
Browse cardiologists in Haddon Heights ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology